LCAR-B4822M-02 Cells in Treating Relapsed/Refractory (R/R) Multiple Myeloma
This is a single arm, open-label, phase 1 study, to determine the safety and efficacy of LCAR-B4822M CAR-T cells in treating patients diagnosed with refractory/relapsed multiple myeloma (r/r MM).
100 项与 LCAR-B4822M 相关的临床结果
100 项与 LCAR-B4822M 相关的转化医学
100 项与 LCAR-B4822M 相关的专利(医药)
100 项与 LCAR-B4822M 相关的药物交易